中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Oral vaccination of tilapia against Streptococcus agalactiae using Bacillus subtilis spores expressing Sip

文献类型:期刊论文

作者Yao, Yuan-Yuan1,4; Chen, Dan-Dan1; Cui, Zheng-Wei1,4; Zhang, Xiang-Yang1,4; Zhou, Yuan-Yuan1,4; Guo, Xia5; Li, Ai-Hua1,6; Zhang, Yong-An1,2,3
刊名FISH & SHELLFISH IMMUNOLOGY
出版日期2019-03-01
卷号86页码:999-1008
关键词Oreochromis niloticus Bacterial infection Vaccine Bacillus Surface display
ISSN号1050-4648
DOI10.1016/j.fsi.2018.12.060
英文摘要Streptococcus agalactiae infections are becoming an increasing problem in aquaculture because of significant morbidity and mortality, which restricts the healthy development of tilapia aquaculture. To seek safe and effective prevention measures, a Bacillus subtilis GC5 surface displayed vaccine was prepared and applied orally in tilapia. The study first showed that recombinant spores can engraft in the tilapia intestine. Then, the effect of protection and the immune responses were evaluated. The results of ELISA showed that Sip-specific antibody in the sera of GC5-Sip-immunized fish can be detected after the first oral administration when compared to the phosphate buffer saline (PBS) control group, and the levels of specific IgM gradually strengthened with boosting, so does the specific antibody against bacteria, proving that humoral immunity was induced. Quantitative real-time PCR (qRT-PCR) results showed that the immune-related gene expression of the gut and spleen exhibited a different rising trend in the GC5-Sip group, revealing that innate immune response and local as well as systemic cellular immunity were induced. The outcome of fish immunized with GC5-Sip spores provided a relative percent survival (RPS) of 41.7% against S. agalactiae and GC5 group had an RPS of 24.2%, indicating that GC5-Sip was safe and effective in protecting tilapia against bacterial infection. Our study demonstrated that the oral administration of B. subtilis spores expressing Sip could cause an effective immune response and offer good resistance to bacterial infection. Our work may lead to the development of new ideas for immunoprophylaxis against S. agalactiae infection.
资助项目State Key Laboratory of Freshwater Ecology and Biotechnology[2016FBZ04]
WOS研究方向Fisheries ; Immunology ; Marine & Freshwater Biology ; Veterinary Sciences
语种英语
WOS记录号WOS:000459528400110
出版者ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
源URL[http://202.127.146.157/handle/2RYDP1HH/6827]  
专题中国科学院武汉植物园
通讯作者Li, Ai-Hua; Zhang, Yong-An
作者单位1.Chinese Acad Sci, Inst Hydrobiol, Wuhan, Hubei, Peoples R China
2.Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China
3.Huazhong Agr Univ, Coll Fisheries, State Key Lab Aquaculture Microbiol, Wuhan, Hubei, Peoples R China
4.Univ Chinese Acad Sci, Beijing, Peoples R China
5.Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Wuhan, Hubei, Peoples R China
6.Freshwater Aquaculture Collaborat Innovat Ctr Hub, Wuhan, Hubei, Peoples R China
推荐引用方式
GB/T 7714
Yao, Yuan-Yuan,Chen, Dan-Dan,Cui, Zheng-Wei,et al. Oral vaccination of tilapia against Streptococcus agalactiae using Bacillus subtilis spores expressing Sip[J]. FISH & SHELLFISH IMMUNOLOGY,2019,86:999-1008.
APA Yao, Yuan-Yuan.,Chen, Dan-Dan.,Cui, Zheng-Wei.,Zhang, Xiang-Yang.,Zhou, Yuan-Yuan.,...&Zhang, Yong-An.(2019).Oral vaccination of tilapia against Streptococcus agalactiae using Bacillus subtilis spores expressing Sip.FISH & SHELLFISH IMMUNOLOGY,86,999-1008.
MLA Yao, Yuan-Yuan,et al."Oral vaccination of tilapia against Streptococcus agalactiae using Bacillus subtilis spores expressing Sip".FISH & SHELLFISH IMMUNOLOGY 86(2019):999-1008.

入库方式: OAI收割

来源:武汉植物园

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。